[Results of the treatment of duodenal ulcer associated with Helicobacter pylori and combined with gastroesophageal reflux disease].

Vasil'ev, Iu V; Nikol'skaia, K A

Vasil'ev, Iu V; Nikol'skaia, K A.

Eksp Klin Gastroenterol ; (6): 61-4, 2005.

Article in Ru | MEDLINE | ID: mdl-17378390

Subject(s)

2-Pyridinylmethylsulfinylbenzimidazoles/therapeutic use; Anti-Bacterial Agents/therapeutic use; Anti-Ulcer Agents/therapeutic use; Duodenal Ulcer/drug therapy; Gastroesophageal Reflux/drug therapy; Helicobacter Infections/drug therapy; Helicobacter pylori; 2-Pyridinylmethylsulfinylbenzimidazoles/administration & dosage; Adolescent; Adult; Aged; Anti-Bacterial Agents/administration & dosage; Anti-Ulcer Agents/administration & dosage; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer/complications; Duodenal Ulcer/microbiology; Female; Gastroesophageal Reflux/complications; Gastroesophageal Reflux/microbiology; Helicobacter Infections/complications; Helicobacter Infections/microbiology; Helicobacter pylori/drug effects; Helicobacter pylori/isolation & purification; Humans; Male; Middle Aged; Rabeprazole; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Gastroesophageal Reflux / Helicobacter pylori / Helicobacter Infections / Duodenal Ulcer / 2-Pyridinylmethylsulfinylbenzimidazoles / Anti-Ulcer Agents / Anti-Bacterial Agents Type of study: Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: Ru Journal: Eksp Klin Gastroenterol Journal subject: GASTROENTEROLOGIA Year: 2005 Document type: Article Country of publication: Russia

Search on Google

Add to My VHL

XML

PubMed Links